What’s Really Happening in Your Brain
You’re probably multitasking right now. Maybe you’re reading this with a podcast playing in the background, or you’ve got three browser tabs open and you’re checking your phone every few minutes. We all do it. We even brag about it on resumes: “Excellent multitasker!” But here’s the uncomfortable truth that neuroscience has been trying to tell us for years—what we call multitasking is mostly an illusion.
What People Actually Mean
When most people say they’re multitasking, they’re describing one of two scenarios. The first is doing multiple automatic activities simultaneously—like walking while talking, or listening to music while folding laundry. The second, and the one that gets more interesting, is rapidly switching attention between different demanding tasks—like answering emails while on a conference call, or texting while watching TV.
The distinction matters because our brains handle these situations very differently. Activities that have become automatic through practice don’t require much conscious attention. You can absolutely walk and chew gum at the same time because neither activity demands your prefrontal cortex’s full attention. But when both tasks require active thinking and decision-making? That’s where things get complicated.
The Brain’s Bottleneck
Here’s what neuroscience tells us: true multitasking—simultaneously processing multiple streams of complex information—is essentially impossible for the human brain. What feels like multitasking is actually rapid task-switching, and your brain pays a price every time it makes that switch.
The limitation comes from something researchers call the “response selection bottleneck.” When you’re performing tasks that require conscious thought, they all funnel through the same neural pathways in your prefrontal cortex. This region can only process one demanding task at a time, so when you think you’re doing two things at once, you’re really just toggling between them very quickly.
Studies using functional MRI brain imaging have shown what happens during this switching process. When people attempt to multitask, researchers observe reduced activity in the regions responsible for each individual task compared to when those tasks are done separately. Your brain literally can’t devote full processing power to both activities simultaneously.
The Switching Cost
Every time you switch from one task to another, there’s a cognitive cost. Your brain needs to disengage from the first task, shift attention, and then reorient to the new task. This happens so quickly—sometimes in tenths of a second—that we don’t consciously notice it. But those microseconds add up.
Sorry, but get ready for some doctor talk. When people switch tasks, imaging studies show increased activation in frontoparietal control and dorsal attention networks, especially in prefrontal regions (like the inferior frontal junction) and parietal cortex (such as intraparietal sulcus). This boosted activity reflects the brain dropping one task set, loading another into working memory, and re‑orienting attention—processes that consume time and neural resources.
Over time, practice can make specific tasks more automatic, reducing average activity in these control networks and allowing smoother coordination of tasks. However, even in trained multitaskers, studies still find evidence for serial queuing of operations in the multiple‑demand frontoparietal network, reinforcing the idea that consciously doing multiple demanding things “at once” is extremely limited.
Research from Stanford University found that people who regularly engage in heavy media multitasking actually perform worse at filtering out irrelevant information and switching between tasks than people who focus on one thing at a time. Essentially, chronic multitaskers become worse at the very thing they practice most.
Even when people train extensively, studies indicate they mainly become faster at switching and coordinating, not truly doing two demanding tasks at once. Experimental work using reaction‑time paradigms shows a reliable “switch cost”: when people change tasks, responses get slower and more error‑prone compared to staying with one task. This cost is one of the strongest signs that most human “multitasking” is serial switching under time pressure rather than genuine simultaneous processing.
The American Psychological Association reports that these mental blocks created by switching between tasks can cost up to 40% of productive time. Think about that for a minute—nearly half your work time potentially lost to the mechanics of jumping between activities.
The Attention Residue Problem
There’s another wrinkle that makes multitasking even less efficient. When you switch away from a task before completing it, part of your attention remains stuck on the unfinished work. Researchers call this “attention residue,” and it reduces your cognitive performance on the next task.
Sophie Leroy, a business professor at the University of Washington, demonstrated this effect in a series of studies. People who switched tasks performed significantly worse on the second task than people who finished the first task before moving on. The unfinished task keeps running in your mental background, using up cognitive resources you need for the new activity.
When “Multitasking” Actually Works
There are legitimate exceptions to the no-multitasking rule, but they’re more limited than most people think. You can successfully combine activities when at least one of them is so well-practiced that it’s become automatic—essentially requiring no conscious thought. You can listen to an audiobook while jogging because your body handles the running on autopilot.
Some research also suggests that certain types of background music or ambient noise can enhance performance on creative tasks, though this seems to work best when the music is familiar and lacks lyrics that compete with language-processing tasks.
Why We Keep Trying
If multitasking is so inefficient, why do we persist? Part of the answer lies in how it feels. Task-switching triggers the release of dopamine, the brain’s reward chemical. Every time you check your phone or switch to a new browser tab, you get a little neurochemical hit. It feels productive, even when it isn’t.
There’s also a cultural element. We live in an attention economy where being constantly connected and responsive feels mandatory. Focusing on one thing can feel like you’re missing out or falling behind, even though the research consistently shows that single-tasking produces better results faster.
It’s worth noting that research consistently shows this gap between perception and performance. People who think they are excellent multitaskers tend to be the worst at it.
The Bottom Line
The evidence is pretty clear: what we call multitasking is really task-switching, and it makes us slower and more error-prone at both activities. Your brain has a fundamental processing limitation that hasn’t changed despite our increasingly multi-screen world. The prefrontal cortex can only fully engage with one complex task at a time, and switching between tasks creates cognitive costs that add up to significant lost productivity and increased mistakes.
This doesn’t mean you should never listen to music while working or that walking while talking will melt your brain. But when you’re doing something that really matters—writing an important email, having a meaningful conversation, learning something new—giving it your full attention will always produce better results than splitting your focus.
America’s Healthcare Paradox: Why We Pay Double and Get Less
By John Turley
On January 5, 2026
In Commentary, Medicine
The healthcare debate in America often circles back to a fundamental question: should we move toward a single-payer system, or is our current mixed public-private model the better path forward? It’s a conversation that gets heated quickly, but when you strip away the politics and look at how different systems actually function around the world, some interesting patterns emerge.
What We Mean by Single-Payer
A single-payer healthcare system means that one entity—usually the government or a government-related organization—pays for all covered healthcare services. Doctors and hospitals can still be private (and usually are), but instead of dealing with dozens of different insurance companies, they bill one source. It’s a lot like Medicare, which is why proponents often call it “Medicare-for-all”.
The key thing to understand is that single-payer isn’t necessarily the same as socialized medicine. In Canada’s system, for instance, the government pays the bills, but doctors are largely in the private sector and hospitals are controlled by private boards or regional health authorities rather than being part of the national government. Compare that to the UK’s National Health Service, where many hospitals and clinics are government-owned and many doctors are government employees.
America’s Current Patchwork
The United States operates what might charitably be called a “creative” approach to healthcare—a complex mix of employer-sponsored private insurance, government programs like Medicare, Medicaid and the VA system, individual marketplace plans, and direct out-of-pocket payments. Government already pays roughly half of total US health spending, but benefits, cost-sharing, and networks vary widely between plans, with little overall coordination. In 2023, private health insurance spending accounted for 30 percent of total national health expenditures, Medicare covered 21 percent, and Medicaid covered 18 percent. Most of the remainder was either paid out of pocket by private citizens or was written off by providers as uncollectible.
Here’s where it gets expensive. U.S. health care spending grew 7.5 percent in 2023, reaching $4.9 trillion or $14,570 per person, accounting for 17.6 percent of the nation’s GDP, and national health spending for 2024 is expected to have exceeded $5.3 trillion or 18% of GDP, and health spending is expected to grow to 20.3 percent of GDP by 2033.
For a typical American family, the costs are real and rising. In 2024, the estimated cost of healthcare for a family of four in an employer-sponsored health plan was $32,066.
The European Landscape
Europe doesn’t have one healthcare model—it has several, and they’re all quite different from what we have in the States. Most of the 35 countries in the European Union have single-payer healthcare systems, but the details vary considerably.
Countries like the UK, Sweden, and Norway operate what are essentially single-payer systems where it is solely the government who pays for and provides healthcare services and directly owns most facilities and employs most clinical and related staff with funds from tax contributions. Then you have countries like Germany, and Belgium that use “sickness funds”—these are non-profit funds that don’t market, cherry pick patients, set premiums or rates paid to providers, determine benefits, earn profits or have investors. They’re quasi-public institutions, not private insurance companies like we know them in America. Some systems, such as the Netherlands or Switzerland, rely on mandatory individually purchased private insurance with tight regulation and subsidies, achieving universal coverage with a structured, competitive market.
The French System
France is particularly noted for a successful universal, government-run health insurance system usually described as a single-payer with supplements. All legal residents are automatically covered through the national health insurance program, which is funded by payroll taxes and general taxation.
Most physicians and hospitals are private or nonprofit, not government employees or facilities. Patients generally have free choice of doctors and specialists, though coordinating through a primary care physician improves access and reimbursement. The national insurer pays a large portion of medical costs (often 70–80%), while voluntary private supplemental insurance covers most remaining out-of-pocket expenses such as copays and deductibles.
France is known for spending significantly less per capita than the United States. Cost controls come from nationally negotiated fee schedules and drug pricing rather than limits on access.
What’s striking is that in 2019, US healthcare spending reached $11,072 per person—over double the average of $5,505 across wealthy European nations. Yet despite spending roughly twice as much per person, American health outcomes often lag behind.
The Outcomes Question
This is where the comparison gets uncomfortable for American exceptionalism. The U.S. has the lowest life expectancy at birth among comparable wealthy nations, the highest death rates for avoidable or treatable conditions, and the highest maternal and infant mortality.
In 2023, life expectancy in comparable countries was 82.5 years, which is 4.1 years longer than in the U.S. Japan manages this with healthcare spending at just $5,300 per capita, while Americans spend more than double that amount.
Now, it’s important to note that healthcare systems don’t operate in a vacuum. Life expectancy is influenced by many factors beyond medical care—diet, exercise, smoking, gun violence, drug overdoses, and social determinants of health all play roles. But when you’re spending twice as much and getting worse results, it suggests the system itself might be part of the problem.
Advantages of Single-Payer Systems
The case for single-payer rests on several compelling points. First, administrative simplicity translates to real cost savings. A study found that the administrative burden of health care in the United States was 27 percent of all national health expenditures, with the excess administrative cost of the private insurer system estimated at about $471 billion in 2012 compared to a single-payer system like Canada’s. That’s over $1 out of every $5 of total healthcare spending just going to paperwork, billing disputes, and insurance company profit and overhead before any patient receives care.
Universal coverage is another major advantage. In a properly functioning single-payer system, nobody goes bankrupt from medical bills, nobody delays care because they can’t afford it, and nobody loses coverage when they lose their job. The peace of mind that comes with knowing you’re covered regardless of employment status or pre-existing conditions is difficult to quantify but enormously valuable.
Single-payer systems also have significant negotiating power. When one entity is buying drugs and services for an entire nation, pharmaceutical companies and medical device manufacturers have much less leverage to charge whatever they want. This helps explain why prescription drug prices in other countries are often a fraction of prices in the U.S.
Disadvantages and Trade-offs
The critics of single-payer systems aren’t wrong about everything. Wait times are a genuine concern in some systems. When prices and overall budgets are tightly controlled, some countries experience longer waits for selected elective surgeries, imaging, or specialty visits, especially if investment lags demand.
In 2024, Canadian patients experienced a median wait time of 30 weeks between specialty referral and first treatment, up from 27.2 weeks in 2023, with rural areas facing even longer delays. For procedures like elective orthopedic surgery, patients wait an average of 39 weeks in Canada.
However, it’s crucial to understand that wait times are not a result of the single-payer system itself but of system management, as wait times vary significantly across different single-payer and social insurance systems. Many European countries with universal coverage don’t experience the same wait time issues that plague Canada.
The transition costs are also substantial. Moving from our current system to single-payer would disrupt a massive industry. Over fifteen percent of our economy is related to health care, with half spent by the private sector. Around 160 million Americans currently have insurance through their employers, and transitioning all of them to a government-run plan would be an enormous administrative and political challenge.
A large national payer can be slower to change benefit designs or adopt new payment models; shifting political majorities can affect funding levels and benefit generosity.
Taxes would need to increase significantly to fund such a system, though proponents argue this would be offset by the elimination of insurance premiums, deductibles, and co-pays. It’s essentially a question of whether you’d rather pay through taxes or through premiums—the money has to come from somewhere.
Advantages of America’s Mixed System
Our current system does have some genuine strengths. Innovation thrives in the American healthcare market. The profit motive, for all its flaws, does drive pharmaceutical research and medical device development. American medical schools and research institutions lead the world in many areas of medicine. Academic medical centers and specialty hospitals deliver advanced procedures and complex care that attract patients internationally.
The system also offers more choice for those who can afford it. If you have good insurance, you typically face shorter wait times for elective procedures and can often see specialists without lengthy delays. Americans with high-quality employer-sponsored coverage give their plans relatively high ratings.
Competition between providers can theoretically drive quality improvements, though this effect is often undermined by the complexity of the market and the difficulty consumers face in shopping for healthcare.
Disadvantages of the Current U.S. System
The most glaring problem is simple: The United States remains the only developed country without universal healthcare, and 30 million Americans remain uninsured despite gains under the Affordable Care Act, and many of these gains will soon be lost. Being uninsured in America isn’t just an inconvenience—it can be deadly. People delay care, skip medications, and avoid preventive screenings because of cost concerns.
The administrative complexity is staggering. Doctors spend enormous amounts of time dealing with insurance companies, prior authorizations, and billing disputes. Hospitals employ armies of billing specialists just to navigate the maze of different insurance plans, each with its own rules, formularies, and coverage determinations. U.S. administrative costs account for ~25% of all healthcare spending, among the highest in the world.
Medical bankruptcy is uniquely American. Even people with insurance can find themselves financially devastated by serious illness. High deductibles, surprise bills, and out-of-network charges create a minefield of potential financial catastrophe. Studies of U.S. bankruptcy filings over the past two decades have consistently found that medical bills and medical problems are a major factor in a large share of consumer bankruptcies. Recent summaries suggest that roughly two‑thirds of US personal bankruptcies involve medical expenses or illness-related income loss, and around 17% of adults with health care debt report declaring bankruptcy or losing a home because of that debt.
The system is also profoundly inequitable. Quality of care often depends more on your job, your income, and your zip code than on your medical needs. Out-of-pocket costs per capita have increased as compared to previous decades and the burden falls disproportionately on those least able to afford it.
What Europe Shows Us
The European experience demonstrates that there isn’t one “right” way to achieve universal coverage. The UK’s NHS, Germany’s sickness funds, and France’s hybrid system all manage to cover everyone at roughly half the per-capita cost of American healthcare. Universal Health Coverage exists in all European countries, with healthcare financing almost universally government managed, either directly through taxation or semi-directly through mandated and government-subsidized social health insurance.
They’ve accomplished this through various combinations of centralized negotiation of drug prices, global budgets for hospitals, strong primary care systems that serve as gatekeepers to more expensive specialist care, emphasis on preventive services, and regulation that prevents insurance companies from cherry-picking healthy patients.
Are these systems perfect? No. One of the major disadvantages of centralized healthcare systems is long wait lists to access non-urgent care, though Americans often wait as long or longer for routine primary care appointments as do patients in most universal-coverage countries. Many European countries are wrestling with funding challenges as populations age and expensive new treatments become available. But they’ve solved the fundamental problem that America hasn’t: they ensure everyone has access to healthcare without the risk of financial ruin.
The Path Forward?
The debate over healthcare in America often presents false choices. We don’t have to choose between Canadian-style single-payer and our current system—there are multiple models we could adapt. We could move toward a German-style system with heavily regulated non-profit insurers. We could create a robust public option that competes with private insurance. We could expand Medicare gradually by lowering the eligibility age over time.
What’s clear from international comparisons is that the status quo is unusually expensive and produces mediocre results. We’re paying premium prices for economy outcomes. Whether single-payer is the answer depends partly on your priorities. Do you value universal coverage and cost control more than unlimited choice? Are you willing to accept potentially longer wait times for non-urgent care in exchange for lower costs and universal access? How much do you trust government to manage a program this large?
These aren’t easy questions, and reasonable people disagree. But the evidence from Europe suggests that universal coverage at reasonable cost is achievable—it just requires us to make some choices about what we value most in a healthcare system.
Sources: